Gilead Sciences to Present at the Cowen & Company 32nd Annual Health Care Conference on Wednesday, March 7
February 29 2012 - 4:30PM
Business Wire
Gilead Sciences, Inc. (Nasdaq:GILD) today announced that its
corporate presentation will be webcast from the Cowen and Company
32nd Annual Health Care Conference in Boston.
Kevin Young CBE, Gilead’s Executive Vice President, Commercial
Operations, and Robin Washington, Gilead’s Senior Vice President
and Chief Financial Officer, will provide an overview of the
company at the Cowen conference on Wednesday, March 7 at 8:40 a.m.
Eastern Time.
To access the live webcast or a replay via the internet log on
to www.gilead.com. Please connect to the company’s website at least
15 minutes prior to the start of the presentation to ensure
adequate time for any software download that may be necessary to
listen to the webcast. The replay will be available for 14 days
following the presentation.
About Gilead
Gilead Sciences is a biopharmaceutical company that discovers,
develops and commercializes innovative therapeutics in areas of
unmet medical need. The company’s mission is to advance the care of
patients suffering from life-threatening diseases worldwide.
Headquartered in Foster City, California, Gilead has operations in
North America, Europe and Asia Pacific.
For more information on Gilead Sciences, please
visit www.gilead.com orcall the Gilead Public Affairs Department at
1-800-GILEAD-5 (1-800-445-3235).
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From May 2024 to Jun 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Jun 2023 to Jun 2024